On July 18th 2017, Flexicare, Inc. completed its acquisition of NeoForce, Inc. from its owners Soleno, Inc. for an undisclosed amount. NeoForce is a fast-growing US based neonatal devices company providing innovative pulmonary resuscitation solutions for inpatient and ambulatory markets. 

The acquisition of NeoForce advances Flexicare’s mission of providing high quality medical devices, expanding its neonatal portfolio and footprint both in the US and internationally.  The combination of the two companies will increase the value Flexicare delivers to its customers and end users. The acquisition is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Flexicare’s wider range of critical care products.

“Flexicare will support NeoForce’s ambition to become a leading supplier of neonatal resuscitation devices, caring for our most vulnerable of patients. This is a long-term strategic investment in a growing sector that we are actively pursuing and will continue to invest in to realize our full potential within this market sector,” said Ghassem Poormand, President Flexicare, Inc.

Over the course of the next few weeks, we will be integrating the business into Flexicare.